These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11484118)

  • 1. Effect of administration of lipoprostaglandin E(1) on physical activity and bone resorption in patients with neurogenic intermittent claudication.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2001; 6(3):242-7. PubMed ID: 11484118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surgical treatment on physical activity and bone resorption in patients with neurogenic intermittent claudication.
    Iwamoto J; Takeda T
    J Orthop Sci; 2002; 7(1):84-90. PubMed ID: 11819138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among physical activity, metacarpal bone mass, and bone resorption marker in 70 healthy adult males.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2002; 7(1):6-11. PubMed ID: 11819125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between physical activity and metacarpal cortical bone mass and bone resorption in hemiplegic patients.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2001; 6(3):227-33. PubMed ID: 11484115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
    Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides.
    Taguchi Y; Gorai I; Zhang MG; Chaki O; Nakayama M; Minaguchi H
    Calcif Tissue Int; 1998 May; 62(5):395-9. PubMed ID: 9541516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication.
    Murakami M; Takahashi K; Sekikawa T; Yasuhara K; Yamagata M; Moriya H
    J Spinal Disord; 1997 Dec; 10(6):499-504. PubMed ID: 9438815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
    Sone T; Miyake M; Takeda N; Fukunaga M
    Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
    Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
    J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic intermittent claudication in lumbar spinal canal stenosis: the clinical relationship between the local pressure of the intervertebral foramen and the clinical findings in lumbar spinal canal stenosis.
    Morishita Y; Hida S; Naito M; Arimizu J; Takamori Y
    J Spinal Disord Tech; 2009 Apr; 22(2):130-4. PubMed ID: 19342935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism in postmenopausal women with lumbar spinal stenosis: analysis of bone mineral density and bone turnover markers.
    Kim HJ; Lee HM; Kim HS; Park JO; Moon ES; Park H; Park SY; Moon SH
    Spine (Phila Pa 1976); 2008 Oct; 33(22):2435-9. PubMed ID: 18923320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model.
    Nakai K; Takenobu Y; Eguchi K; Takimizu H; Honjo K; Akimaru S; Maegawa H; Marsala M; Katsube N
    Anesth Analg; 2002 Jun; 94(6):1537-41, table of contents. PubMed ID: 12032022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial.
    Belcaro G; Nicolaides AN; Agus G; Cesarone MR; Geroulakos G; Pellegrini L; De Sanctis MT; Incandela L; Ricci A; Mondani P; De Angelis R; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Dugall M; Bucci M; Martines G; Ferrari PG; Corsi M; Di Francescantonio D
    Angiology; 2000 Aug; 51(8 Pt 2):S15-26. PubMed ID: 10959507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.